Risk Considerations
Investors should note that the Xtrackers ETFs & ETCs are not capital protected or guaranteed and investors in each Xtrackers ETF or ETC should be prepared and able to sustain losses up to the total capital invested. The value of an investment in an Xtrackers ETF or ETC may go down as well as up and past performance does not predict future returns. Investment in Xtrackers ETFs or ETCs involve risks. For a list of related risks please click on the Risks and Terms tab.
Important security note: Warning of attempted fraud in the name of DWS
We have detected that fraudulent individuals are misusing the "DWS" trademark and the names of DWS employees on the internet and social media. These fraudsters are operating fake websites, Facebook pages, WhatsApp groups and Mobile Apps. Please be aware that DWS does not have any Facebook Ambassador profiles or WhatsApp chats. If you receive any unexpected calls, messages, or emails claiming to be from DWS, exercise caution and do not make any payments or disclose personal information. We encourage you to report any suspicious activity to info@dws.com, including any relevant documents and the original fraudulent email. Additionally, if you believe you have been a victim of fraud, please notify your local authorities and take steps to protect yourself.

Date | From Sep 2016 to Sep 2017 | From Sep 2017 to Sep 2018 | From Sep 2018 to Sep 2019 | From Sep 2019 to Sep 2020 | From Sep 2020 to Sep 2021 | From Sep 2021 to Sep 2022 | From Sep 2022 to Sep 2023 | From Sep 2023 to Sep 2024 | From Sep 2024 to Sep 2025 | From Sep 2025 to Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return (USD) | -- | -- | -- | -- | -- | -- | -- | -- | 3.43% | -1.46% |
| Benchmark (USD) | -- | -- | -- | -- | -- | -- | -- | -- | 3.48% | -1.41% |
Past performance does not predict future returns. Performance shown above is net of fund fees and any index replication costs. ETF performance calculation includes reinvested dividends. Performance figures are reported, based on the values as of the last business day of the relevant reporting month.
The All-in fee comprises the Fixed Fee and the Management Company Fee. The Fixed Fee covers certain administrative expenses including the Administrative Agent Fee, the Custodian Fee, the Registrar, Transfer Agent and Listing Agent Fee and the annual tax in Luxembourg (if any) (the "Taxe d'Abonnement"). Further details are available in the Xtrackers, Xtrackers II and Xtrackers (IE) Plc prospectuses.
“Bloomberg®” and Bloomberg U.S. Treasury 3-7 Year are service marks of Bloomberg Finance L.P. and its affiliates, including Bloomberg Index Services Limited (“BISL”), the administrator of the index (collectively, “Bloomberg”) and have been licensed for use for certain purposes by Xtrackers II. Bloomberg is not affiliated with Xtrackers II and Bloomberg does not approve, endorse, review, or recommend US Treasuries 3-7 UCITS ETF. Bloomberg does not guarantee the timeliness, accurateness, or completeness of any data or information relating to US Treasuries 3-7 UCITS ETF.
Download historical data in Excel format.
From January 3, 2018, on, investment firms which engage in investment services under the Directive 2014/65/EU (Markets in Financial Instruments Directive – „MiFID II“) have to comply with certain new requirements for the distribution of investment funds under the respective national implementation laws in the individual Member States of the European Union.
As part of the new rules, investment firms are required to identify or review and refine, as the case may be, the target market for each financial instrument they distribute. This means that they have to specify the type(s) of client for whose needs, characteristics and objectives the financial instrument is compatible. Further, MiFID II introduces new cost disclosure requirements which aim at increasing cost transparency for investors on a quantitative as well as on a qualitative level. Accordingly, investment firms have to disclose all relevant costs to the client; i.e. those relevant to the investment service and those relevant to the product. The costs have to be aggregated and provided ex-ante (i.e. before the client purchases a product) as well as ex-post, as the case may be, during the lifetime of the investment on at least a yearly basis.
The asset management companies pertaining to DWS support this process by delivering relevant data to the investment firms to enable them to fulfil their new legal obligations. To provide an enhanced level of transparency, the target market and material product cost related MiFID II data are additionally displayed here below with regard to the relevant investment fund.
Important Notes:
The following data is provided on a voluntary basis only and may as such, without further explanations and additional information, i.e. in particular the information contained in the relevant sales documentation of the investment fund (e.g. fund prospectus, KIID) not be sufficient or suitable to assist a potential investor in taking an informed investment decision. It is therefore recommended that investors also carefully read the sales documentation prior to any potential investment decision, and, in particular in case of any questions, consult their investment advisor.
The information on ongoing product costs may deviate from the cost data contained in the relevant sales documentation of the investment fund (e.g. the KIID). The reason for this is that the requirements to display ongoing costs and charges at product level pursuant to the new MiFID II regulations go beyond the existing disclosure regulations applicable to the asset management companies under their relevant regulatory frameworks (i.e. the UCITS Directive or the AIFM Directive and their respective national implementation laws). For example, the estimated transaction costs of an investment fund are not part of the description of the ongoing costs in the relevant KIID established by the management company. Under MiFID II, an investment firm will however have to disclose such costs as part of the costs of the product in good time prior to a potential investor’s investment decision. Thus, the ongoing costs related to the product displayed here below as “total ongoing costs of the product” may, due to differences in the calculation and disclosure methodology, deviate from the sales documentation of the fund.
DWS does not accept any responsibility or liability whatsoever in relation to the data except in case of gross negligence or wilful misconduct.
Same asset class
Same region